105 related articles for article (PubMed ID: 19372704)
1. Healthcare expenditure and resource utilization in patients with anaemia and chronic kidney disease: a retrospective claims database analysis.
Wish J; Schulman K; Law A; Nassar G
Kidney Blood Press Res; 2009; 32(2):110-8. PubMed ID: 19372704
[TBL] [Abstract][Full Text] [Related]
2. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
[TBL] [Abstract][Full Text] [Related]
3. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
4. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease.
Lefebvre P; Duh MS; Buteau S; Bookhart B; Mody SH
J Am Soc Nephrol; 2006 Dec; 17(12):3497-502. PubMed ID: 17082245
[TBL] [Abstract][Full Text] [Related]
5. Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.
Schumock GT; Andress DL; Marx SE; Sterz R; Joyce AT; Kalantar-Zadeh K
Nephron Clin Pract; 2009; 113(1):c54-61. PubMed ID: 19590235
[TBL] [Abstract][Full Text] [Related]
6. Costs of managing anemia with erythropoiesis-stimulating agents during hemodialysis: a time and motion study.
Schiller B; Doss S; DE Cock E; Del Aguila MA; Nissenson AR
Hemodial Int; 2008 Oct; 12(4):441-9. PubMed ID: 19090867
[TBL] [Abstract][Full Text] [Related]
7. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
8. Characterizing hospitalizations of end-stage renal disease patients on dialysis and inpatient utilization of erythropoiesis-stimulating agent therapy.
Brophy DF; Daniel G; Gitlin M; Mayne TJ
Ann Pharmacother; 2010 Jan; 44(1):43-9. PubMed ID: 20028955
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs.
Wei SY; Chang YY; Mau LW; Lin MY; Chiu HC; Tsai JC; Huang CJ; Chen HC; Hwang SJ
Nephrology (Carlton); 2010 Feb; 15(1):108-15. PubMed ID: 20377778
[TBL] [Abstract][Full Text] [Related]
10. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Joyce AT; Smith P; Khandker R; Melin JM; Singh A
J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
[TBL] [Abstract][Full Text] [Related]
11. Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and older.
Ibrahim HN; Ishani A; Guo H; Gilbertson DT
Nephrol Dial Transplant; 2009 Oct; 24(10):3138-43. PubMed ID: 19451656
[TBL] [Abstract][Full Text] [Related]
12. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
[TBL] [Abstract][Full Text] [Related]
13. Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients.
Vekeman F; Yameogo ND; Lefebvre P; Bailey RA; McKenzie RS; Piech CT
J Med Econ; 2010; 13(4):673-80. PubMed ID: 21050062
[TBL] [Abstract][Full Text] [Related]
14. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
Artunc F; Risler T
Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
[TBL] [Abstract][Full Text] [Related]
15. General medical care among patients with chronic kidney disease: opportunities for improving outcomes.
Kausz AT; Guo H; Pereira BJ; Collins AJ; Gilbertson DT
J Am Soc Nephrol; 2005 Oct; 16(10):3092-101. PubMed ID: 16079268
[TBL] [Abstract][Full Text] [Related]
16. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.
Thorp ML; Johnson ES; Yang X; Petrik AF; Platt R; Smith DH
Nephrology (Carlton); 2009 Apr; 14(2):240-6. PubMed ID: 19207866
[TBL] [Abstract][Full Text] [Related]
17. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study.
Thilly N; Boini S; Kessler M; Briançon S; Frimat L
J Eval Clin Pract; 2009 Feb; 15(1):121-8. PubMed ID: 19239592
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
[TBL] [Abstract][Full Text] [Related]
20. Anaemia management prior to dialysis: cardiovascular and cost-benefit observations.
Collins AJ
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 2():ii2-6. PubMed ID: 12819293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
